Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivascardiology

Paeds Vivas · cardiology

Cardiogenic shock and mechanical circulatory support — branching viva

Branching viva from the school-age child who presents in compensated cardiogenic shock after a viral illness, through the cautious-fluid and inotrope resuscitation and the SCAI staging, the escalation to venoarterial extracorporeal membrane oxygenation when shock becomes refractory, the framing of fulminant myocarditis as a bridge to recovery, and the adolescent on a durable ventricular assist device awaiting transplant, whose device choice, goals of support and anticoagulation complication burden are tested.

branching clinical structured oral2 min readVerification in progress

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
You are the paediatric registrar in the emergency department and the paediatric intensive care unit. The examiner asks you to work through three children: a six-year-old boy who arrives three days after a viral illness cold, mottled and galloping with a normal blood pressure and a raised lactate; the same boy six hours later in refractory cardiogenic shock; and a fourteen-year-old boy with dilated cardiomyopathy being evaluated for a durable ventricular assist device. The examiner releases information in stages.

Stage 1 — The compensated presentation

The examiner presents a six-year-old boy three days after a viral illness. He is cold and mottled with weak pulses, a four-second capillary refill, oliguria and a gallop rhythm. His blood pressure is 95/60 (normal for age) and his lactate is 5.2 mmol/L. The echocardiogram shows globally hypokinetic ventricles. [2]

  • Why does the normal blood pressure not exclude shock, and what bedside feature confirms the shock is cardiogenic? Children vasoconstrict to preserve blood pressure until late, so the perfusion state defines shock; the gallop and congestion confirm a cardiogenic cause. [13]
  • Describe your initial fluid strategy and contrast it with septic shock. Five-to-ten millilitre-per-kilogram aliquots with reassessment for congestion, deliberately less than the ten-to-twenty of septic shock, because the failing ventricle tolerates volume poorly. [12]
  • Assign his SCAI stage and state the trigger for escalation. He is stage C (classic hypoperfusion needing inotropes); the trigger for mechanical support is stage E, refractory collapse. [2]

Stage 2 — The refractory deterioration

Six hours later his blood pressure falls to 60/40, the lactate rises to 8 mmol/L, and he remains oliguric on milrinone, dobutamine and adrenaline. The examiner asks for the definitive intervention. [10]

  • What has happened, and what is the definitive next step? He is now in refractory cardiogenic shock (stage D to E); deploy venoarterial extracorporeal membrane oxygenation as the first-line rescue, early. [10] [8]
  • What is the goal of support in fulminant myocarditis, and what prognosis should you state to the family? Bridge to recovery; fulminant myocarditis often recovers near-normal ventricular function once supported through the storm. [15]
  • What complications must you counsel the family about? Bleeding and thromboembolic stroke from mandatory anticoagulation, infection, haemolysis, limb ischaemia and multiorgan failure from delayed deployment. [7] [8]
Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References16ShowHide
  1. [1]Amdani S; Rossano JW; Wilmot I; et al Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation, 2024.PMID 38808502
  2. [2]Baran DA; Grines CL; Bailey S; et al SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society for Cardiovascular Angiography and Interventions (SCAI), and the Society of Thoracic Surgeons (STS). Catheter Cardiovasc Interv, 2019.PMID 31104355
  3. [3]Fraser CD Jr; Jaquiss RD; Rosenthal DN; et al Prospective trial of a pediatric ventricular assist device. N Engl J Med, 2012.PMID 22873533
  4. [4]Fraser CD Jr; Jaquiss RD The Berlin Heart EXCOR Pediatric ventricular assist device: history, North American experience, and future directions. Ann N Y Acad Sci, 2013.PMID 23750961
  5. [5]Almond CS; Morales DL; Blackstone MH; et al Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale. Am Heart J, 2011.PMID 21884857
  6. [6]Rihal CS; Naidu SS; Givertz MM; et al 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care. J Card Fail, 2015.PMID 26036425
  7. [7]Assmann A; Boekstegers P; Brcic I; et al Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice guideline. ESC Heart Fail, 2022.PMID 34811959
  8. [8]Bembea MM; Agus M; Akcan-Arikan A; et al Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs. Pediatr Crit Care Med, 2023.PMID 36995097
  9. [9]Bhaskar P; Dhar R; Stephenson AL; et al Use of ECMO for Cardiogenic Shock in Pediatric Population. J Clin Med, 2021.PMID 33917910
  10. [10]Sachdev A; Chauhan S; Gupta D; et al Refractory pediatric cardiogenic shock: A case for mechanical support. Indian J Crit Care Med, 2016.PMID 27994387
  11. [11]Schranz D Pharmacological Heart Failure Therapy in Children: Focus on Inotropic Support. Handb Exp Pharmacol, 2020.PMID 31707469
  12. [12]Burkhardt BEA; Rucker G; Stiller B Inotropes for the prevention of low cardiac output syndrome and mortality for paediatric cardiac surgery patients. Cochrane Database Syst Rev, 2024.PMID 39588800
  13. [13]Rossano JW; Cherng An V; Lin KY; et al Heart failure in children: etiology and treatment. J Pediatr, 2014.PMID 24928699
  14. [14]Esangbedo ID; Biagas KV; Ma X; et al Pediatric Extracorporeal Cardiopulmonary Resuscitation: A Systematic Review. Pediatr Crit Care Med, 2020.PMID 32345933
  15. [15]Feng T; Zhao Y; Li L; et al Clinical outcomes of VA-ECMO in children with fulminant myocarditis: a single-centre case series. BMC Pediatr, 2026.PMID 42056983
  16. [16]Levin A Levosimendan. J Pediatr Intensive Care, 2013.PMID 31214430
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousCardiac transplantation and ventricular assist devices — branching vivacardiologyNextCardiomyopathies in children — branching vivacardiology